Amundi ESTOXX50 Dly -1X ... Aktie - BSX

Rendering Error

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

7,997

Gebot

7,985

Fragen

8,05

Volumen

10.200

7,883 Tagesbereich 7,969

0,00 52-Wochen-Bereich 0,00

Handelsende

7,905

Handelsbeginn

7,883

Letzte Trade

10000

7.969

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

NATICK, Mass., Jan. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial...

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

NATICK, Mass., Dec. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the pricing of a public offering of $2...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Three models of stenting system now available for palliative treatment of malignant common bile duct strictures NATICK, Mass., Oct. 6...

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

NATICK, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Morgan Stanley...

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

NATICK, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Thomas Weisel...

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

NATICK, Mass. and BARCELONA, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced long-term data from the...

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC NATICK, Mass., and BARCELONA, Spain...

Boston Scientific Announces Schedule for European Society of Cardiology Congress

NATICK, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the schedule of the Company's major...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AMIMedondo Holding AG	0,498 € (91,54%)	110
8AW0Ocean Biomedical Inc	0,094 € (77,36%)	521,78k
51JVivoPower International PLC	3,72 € (73,83%)	45,8k
PU11Social Chain AG	0,025 € (66,67%)	23,7k
4NM1China Evergrande New Energy Vehicle Group Limited	0,0223 € (57,04%)	68,3k
EJ7Energy Resources of Australia	0,001 € (-33,33%)	1,4M
E3O1Nexoptic Technology Corp	0,006 € (-29,41%)	70,88k
PA8Paion AG	0,0196 € (-27,94%)	9,58k
K1SNKlondike Silver Corporation	0,013 € (-27,78%)	100k
CNWCodon AG	0,013 € (-25,71%)	5k
D7GNel ASA	0,226 € (-7,57%)	9,31M
DMJDynaCERT Inc	0,1275 € (10,87%)	7,11M
DMLSayona Mining Limited	0,0109 € (-5,22%)	6,63M
FMKEcograf Limited	0,253 € (8,58%)	4,53M
E3BEutelsat Communications	4,86 € (44,47%)	2,66M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Amundi ESTOXX50 Dly -1X Inv UCITS ETF A (BSX)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

BSX Neueste Nachrichten

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Boston Scientific Announces Schedule for European Society of Cardiology Congress

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Amundi ESTOXX50 Dly -1X Inv UCITS ETF A (BSX) Börsenkurse

Amundi ESTOXX50 Dly -1X Inv UCITS ETF A (BSX)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

BSX Neueste Nachrichten

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Boston Scientific Announces Schedule for European Society of Cardiology Congress

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP